• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
`False-positive` and `false-negative` test results in clinical urine drug
`False-positive` and `false-negative` test results in clinical urine drug

... has a narrow window of detection in the urine (typically <12 h), but it is a specific marker for heroin administration. On the other hand, nonpharmaceutical heroin is prepared from opium and contains codeine and 6-acetylcodeine (6-AC) as manufacturing impurities [5,6] . 6-AC is rapidly metabolized i ...
Impurities in new drug products, Q3B (R2)
Impurities in new drug products, Q3B (R2)

... estimated to be present at a level greater than (>) the identification threshold given in Attachment 1. For degradation products known to be unusually potent or to produce toxic or unexpected pharmacological effects, the quantitation/detection limit of the analytical procedures should be commensurat ...
Sample Chapter
Sample Chapter

... frequently be explained through pharmacokinetic or pharmacodynamic changes.5 Older patients take more medications than younger persons, yet major drug studies are performed primarily on individuals younger than 55 years of age. The effects of aging on drug metabolism are complex and difficult to pre ...
Therapeutic Drug Monitoring in the Geriatric Patient
Therapeutic Drug Monitoring in the Geriatric Patient

... frequently be explained through pharmacokinetic or pharmacodynamic changes.5 Older patients take more medications than younger persons, yet major drug studies are performed primarily on individuals younger than 55 years of age. The effects of aging on drug metabolism are complex and difficult to pre ...
Document
Document

...  S-warfarin is more potent and metabolized by CYP2C9  R-warfarin is metabolized by CYP1A1, 1A2 and 3A4  Pharmacologic target is VKORC1 ...
Module 3. Pharmaceutical care during OTC medications vacation
Module 3. Pharmaceutical care during OTC medications vacation

... B. Blood urea nitrogen (BUN) and creatinine C. * Blood pressure D. Level of consciousness E. Pressure within the heart 75. Cause a decrease in liver triacylglycerol synthesis by limiting available free fatty acids needed as building blocks for this pathway: A. Cholestyramine B. * Niacin C. Clofibrat ...
Development, characterization and in vitro biological
Development, characterization and in vitro biological

... their vertebrate hosts [2,3]. These parasites can originate two types of diseases: visceral or cutaneous leishmaniases.Although the visceral form is more aggressive, the cutaneous leishmaniases (CL) has received considerable attention in recent research because most patients are resistant to current ...
PersPectIves
PersPectIves

... well as that of other drugs. To provide a comprehensive in vitro survey of drug disposition determinants, a laboratory needs the capability to per‑ form the diverse assay types mentioned above, many of which must be developed in-house. Because of the current lack of a comprehensive toolset and the r ...
ORGANIC VOLATILE IMPURITIES AND THEIR REGULATORY LIMITS ( AS A PART OF PREFORMULATION)
ORGANIC VOLATILE IMPURITIES AND THEIR REGULATORY LIMITS ( AS A PART OF PREFORMULATION)

... level, the drug product should be tested to ascertain whether the formulation process has ...
The Need and Importance of Dose Flexibility - Accu
The Need and Importance of Dose Flexibility - Accu

... appeared in the mid 19th century offering improvements in the palatability of medications. Later, they were used as a means to individualize dosages through compounding. They have become increasingly prevalent, comprising approximately 21% of all U.S. oral solid medications today.7 The principal di ...
FORMULATION AND EVALUATION OF ERGOTAMINE TARTRATE LYOPHILIZED NASAL INSERT
FORMULATION AND EVALUATION OF ERGOTAMINE TARTRATE LYOPHILIZED NASAL INSERT

... nasal mucosa then it transform into gel due to uptake of water which is a prerequisite for bioadhesion. The vertical displacement of inserts on an agar was used as a measure of bioadhesion potential. Almost instantaneous displacement and therefore a low bioadhesion potential was obtained with HPMC E ...
GASTRO-RETENTIVE DRUG DELIVERY SYSTEM CONTENTS
GASTRO-RETENTIVE DRUG DELIVERY SYSTEM CONTENTS

... 1.Density: GRT is a function of dosage form buoyancy that is dependent on the density. 2.Size: Dosage form units with a diameter of more than 7.5mm are reported to have an increased GRT compared with those with a diameter of 9.9mm. 3. Shape of dosage form: Tetrahedron and ring shaped devices with a ...
FDA Regulation of Mobile Medical Apps
FDA Regulation of Mobile Medical Apps

... June 2014 Notice of Draft Guidance The FDA states: “This draft guidance is intended to describe FDA’s current thinking about how manufacturers, packers, and distributors . . . of prescription human and animal drugs . . . and medical devices for human use . . . that choose to present benefit informa ...
Preparation and Evaluation of Minoxidil Gels
Preparation and Evaluation of Minoxidil Gels

... reveals that minoxidil was released by diffusion for 6 h of the study (R2=0.8709 to 0.9643). This may be due to the formation of a thin film upon application of gel as the alcohol and water component evaporates. The thermodynamic activity of minoxidil release is likely to be modified by the non-vola ...
‘-4 L
‘-4 L

... participants were taken, including systolic and diastolic blood pressure, pulse rate, and weight. No deaths or serious adverse events were reported during this 3-month study. CDER thoroughly reviewed the data from this study and concluded that these data supported the conclusion that Duramed’s synth ...
In vitro Evaluation of the Effect of Combination of Hydrophilic and
In vitro Evaluation of the Effect of Combination of Hydrophilic and

Practical Use - Clinician`s Brief
Practical Use - Clinician`s Brief

... Several cardiac and vasoactive drugs have potent hemodynamic effects that can markedly affect the outcome of critically ill veterinary patients. Drugs that have a rapid onset of action and a short half-life are ideal for CRI delivery because the veterinarian can provide a continuous, steady-state co ...
transdermal patches based on solid lipid
transdermal patches based on solid lipid

... permeated by using nanoparticles made by polymethacrylic acid.  Histopathological studies confirm that M-SLN transdermal patches is biocompatible for use.  When prescribing transdermal Metformin, one advantage and key point is that the patient dose is generally only 10% of their oral dose. For ex. ...
The Most Dangerous Drug
The Most Dangerous Drug

... with significant warnings. Chemically, aspirin is acetylsalicylic acid, sometimes referred to as ASA. It’s a member of the class of medicines known as non-steroidal anti-inflammatory drugs, or NSAIDs. The name Aspirin® was a trademark of Bayer, but they lost the patent in certain countries including ...
DEPARTMENT  OF  HEALTH  AND  HUMAN ...
DEPARTMENT OF HEALTH AND HUMAN ...

... a “dietary ingredient” within the meaning of 21 U.S.C. 321(ff)(l). Therefore, notwithstanding the discussion below of the information you rely upon as evidence that your product is reasonably expected to be safe, FDA cannot determine, at this time, whether your product contains a dietary ingredient ...
Role of cytochrome P450 in drug interactions | SpringerLink
Role of cytochrome P450 in drug interactions | SpringerLink

... involved [67]. There are three basic types of enzyme inhibition (competitive, non-competitive and uncompetitive), and clinical effects are influenced by these basic mechanisms [68,69]. The first type is competitive inhibition between inhibitor and substrate for the same binding site on an enzyme. Th ...
ASSESSMENT OF PHARMACEUTICAL QUALITY CONTROL AND EQUIVALENCE OF VARIOUS
ASSESSMENT OF PHARMACEUTICAL QUALITY CONTROL AND EQUIVALENCE OF VARIOUS

... The essential drug concept supports the use of generic medicines so as to improve access to essential medicines via drug price control [2]. A generic medicine is defined as an exact simulation of an established drug, not protected by a patent and promoted with the chemical name of the active ingredi ...
A comparison of the drugs taken in fatal and nonfatal self
A comparison of the drugs taken in fatal and nonfatal self

... agglomeration of Berne and coming to medical attention. The population of Berne and surroundings can be considered representative of Switzerland in general, as there is little difference in the important sociodemographic variables. Of course, many cases of attempted suicide not coming to medical att ...
Classification and the Defined Daily Dose (DDD)
Classification and the Defined Daily Dose (DDD)

... (i.e. number of DDDs/package) at the medicinal product package level • Request new ATC codes and DDDs if they are not available • Describe the ATC/DDD version used, i.e. give proper references in all publications and statistics ...
Preparation, characterization, and in vivo evaluation of - e
Preparation, characterization, and in vivo evaluation of - e

... nasal mucosa from drugs or their excipients.10 However, the nasal route is one of the focused delivery options for the treatment of CNS ailments due to a direct connection between brain and nose compartment through the olfactory route as well as peripheral circulation.11 This course of drug transpor ...
< 1 ... 42 43 44 45 46 47 48 49 50 ... 196 >

Compounding

Pharmaceutical compounding (done in compounding pharmacies) is the creation of a particular pharmaceutical product to fit the unique need of a patient. To do this, compounding pharmacists combine or process appropriate ingredients using various tools. This may be done for medically necessary reasons, such as to change the form of the medication from a solid pill to a liquid, to avoid a non-essential ingredient that the patient is allergic to, or to obtain the exact dose(s) needed or deemed best of particular active pharmaceutical ingredient(s). It may also be done for more optional reasons, such as adding flavors to a medication or otherwise altering taste or texture. Compounding is most routine in the case of intravenous/parenteral medication, typically by hospital pharmacists, but is also offered by privately owned compounding pharmacies and certain retail pharmacies for various forms of medication. Whether routine or rare, intravenous or oral, etc., when a given drug product is made or modified to have characteristics that are specifically prescribed for an individual patient, it is known as ""traditional"" compounding.Due to the rising cost of compounding and the shortage of drugs, many hospitals have shown a tendency to rely more upon large-scale compounding pharmacies to meet their regular requirement, particularly of sterile-injectable medications. When compounding is done on bulk production of a given formulation rather than patient-specific production, it is known as ""non-traditional"" compounding (which, as discussed below, is arguably not ""compounding"" but rather ""manufacturing""). This development raises concerns about patient safety and makes a case for proper regulatory control and monitoring.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report